Share price: 104.00p

Additional listing/TVR

11th May 2011

The Company announces that on 10 May 2011 it resolved to issue 5,744,670 new ordinary shares of 10p each to vendors of businesses previously acquired by the Group and certain employees of the Group. These shares are to be issued pursuant to the terms of earnout agreements under the share purchase agreements in relation to The MSI Consultancy Limited and 2CV Limited.

Application has been made for these shares to be admitted to trading on AIM and admission is expected to occur on 16 May 2011. The Company’s issued share capital, following the admission of the 5,744,670 new shares, will be 78,526,706 ordinary shares of 10 pence each (“Ordinary Shares”), all with voting rights. The Company holds 237,000 Ordinary Shares in treasury at the date of this announcement. The total number of current voting rights in the Company will therefore be 78,289,706 shares.

The above figure (78,289,706 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA’s Disclosure and Transparency Rules.

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150